Document is current

Any future updates will be listed below

Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease

Crossref DOI link: https://doi.org/10.1038/s41409-023-02144-8

Published Online: 2023-11-06

Published Print: 2024-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark